LYMPHOMA COALITION
is a worldwide network of patient organisations with a full or partials focus on providing support to those affected by lymphoma, including chronic lymphocytic leukemia.
Find a Member Organisation Near You
The 2024 Global Patient Survey (GPS) on Lymphoma & CLL is now available!
View ReportSearch The Resource Library
Browse information on lymphoma diagnosis, treatment & survivorship
🎉Exciting News! The Newly Updated Lymphoma Coalition Website is Live 🎉
Navigating lymphoma information, resources, and insights has never been easier. The updated website offers a more intuitive experience, ensuring the latest data, research, and patient perspectives are readily accessible.
Explore the new platform and discover enhanced tools designed to support the global lymphoma community.
🔗 www.lymphomacoalition.org
#lymphomacoalition #lymphomaawareness #HealthcareInnovation #PatientAdvocacy ... See MoreSee Less
📢 The 2025 Tandem Meetings Begin Today! 🌍
The 2025 Tandem Meetings on cellular therapy and transplantation are taking place from 12-15 February in Honolulu, Hawai'i. This key event brings together experts, researchers, and healthcare professionals to explore the latest advancements in haematopoietic cell transplantation (HCT), cellular therapy, and gene therapy.
Lorna Warwick, CEO of Lymphoma Coalition, will be participating, engaging in discussions on critical developments in the field.
🔗 Learn more: www.tandemmeetings.com/
#tandemmeetings #celltherapy #transplantation #lymphoma #HCT #MedicalAdvancements ... See MoreSee Less
📢 Global Cancer Coalitions Network Survey
The Global Cancer Coalitions Network (GCCN) is seeking input from patient organisations worldwide through an important survey. With the five-year anniversary of the World Health Organisation’s declaration of COVID-19 as a pandemic approaching, this is a key opportunity to highlight ongoing challenges and evolving priorities in cancer advocacy.
The survey explores the long-term impact of COVID-19 on funding, services, and advocacy efforts. Insights will help strengthen support for patient organisations and guide future initiatives.
Make your voice heard – the survey closes on 14 February.
Complete the survey now: www.surveymonkey.com/r/RKGMLHT ... See MoreSee Less
🔬 Exploring Patient-Reported Side Effects in CAR-T Therapies at the EHA-EBMT Meeting
Natacha Bolaños, Head of Membership & Alliances, is attending the EHA-EBMT 7th European CAR T-cell Meeting from 6-8 February in Strasbourg. She will be presenting on patient-reported side effects in CAR-T versus other therapies for relapsed lymphomas and chronic lymphocytic leukaemia (CLL).
The insights are based on findings from the Lymphoma Coalition’s 2024 Global Patient Survey.
Additionally, Natacha will chair the session "Optimising Long-Term Outcomes of Patients with B Cell Lymphoma" on Saturday, 8 February, from 9:45 to 11:15 AM (Room Schweitzer).
📖 Find out more about the programme: www.ebmt.org/events/eha-ebmt-7th-european-car-t-cell-meeting
#CAR-T #Lymphoma #PatientOutcomes #EHAEBMT #CancerResearch ... See MoreSee Less
🌍 Today is #WorldCancerDay, we honour both our uniqueness and our shared commitment to improving cancer care worldwide.
By standing together, we can build a future where everyone receives the support and care they deserve.
Learn how you can make a difference at worldcancerday.org
#UnitedByUnique #WorldCancerDay ... See MoreSee Less
📢 Happening Now: CDDF Annual Conference 2025
The Cancer Drug Development Forum (CDDF) Annual Conference 2025 is underway in Noordwijk, the Netherlands (3-5 February), bringing together experts from across the oncology community to drive progress in cancer drug development, regulatory science, and patient access.
🌍 Natacha Bolaños, Head of Membership & Alliances at Lymphoma Coalition, is participating in the discussions, contributing valuable insights on patient advocacy and equitable access to care.
🔗 Learn more: cddf.org/events/upcoming-events/cddf-annual-conference-2025/event-outline/
#CDDF2025 #PatientAdvocacy #LymphomaCoalition ... See MoreSee Less